Business ❯Mergers and Acquisitions

Pharmaceutical Industry

Drug Development Rare Diseases Drugs Rare Disease Drugs AI in Drug Development Eli Lilly Competition Regulatory Approval Cancer Treatment Cancer Treatments Biotech Companies Recent Acquisitions Orchard Therapeutics Acquisition Perrigo Co Ophthalmology

Chemist Warehouse-Sigma Merger Approved, Creating $8.8 Billion Pharma Giant

Eli Lilly Acquires Morphic for $3.2 Billion

Merck to Acquire EyeBio for Up to $3 Billion

FDA Approves Revolutionary $4.25 Million Gene Therapy for Rare Genetic Disorder

AstraZeneca Acquires Fusion Pharmaceuticals in $2.4 Billion Deal to Boost Cancer Treatment Pipeline

Roche to Acquire Carmot Therapeutics in $2.7 Billion Deal

AbbVie Acquires ImmunoGen for $10.1 Billion, Gaining Access to Promising Ovarian Cancer Drug

FTC Sues to Stop Amgen's Multibillion-Dollar Acquisition of Horizon Therapeutics

Merck Acquires Prometheus Biosciences for $10 Billion Amid Keytruda Revenue Loss Fears